| Structural and functional alterations of skeletal muscle microvasculature in dystrophin-deficient mdx mice C Latroche, B Matot, A Martins-Bach, D Briand, B Chazaud, C Wary, ... The American journal of pathology 185 (9), 2482-2494, 2015 | 52 | 2015 |
| Metabolic profile of dystrophic mdx mouse muscles analyzed with in vitro magnetic resonance spectroscopy (MRS) AB Martins-Bach, AC Bloise, M Vainzof, SR Rabbani Magnetic resonance imaging 30 (8), 1167-1176, 2012 | 37 | 2012 |
| Phenotypic and genetic associations of quantitative magnetic susceptibility in UK Biobank brain imaging C Wang, AB Martins-Bach, F Alfaro-Almagro, G Douaud, JC Klein, A Llera, ... Nature neuroscience 25 (6), 818-831, 2022 | 34 | 2022 |
| A normal life without muscle dystrophin M Zatz, NM Vieira, E Zucconi, M Pelatti, J Gomes, M Vainzof, ... Neuromuscular Disorders 25 (5), 371-374, 2015 | 22 | 2015 |
| Quantitative T2 combined with texture analysis of nuclear magnetic resonance images identify different degrees of muscle involvement in three mouse models of muscle dystrophy … AB Martins-Bach, J Malheiros, B Matot, PCM Martins, CF Almeida, ... PloS one 10 (2), e0117835, 2015 | 22 | 2015 |
| Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model A Fongy, S Falcone, J Lainé, B Prudhon, A Martins-Bach, M Bitoun Scientific reports 9 (1), 1580, 2019 | 18 | 2019 |
| Non-invasive assessment of skeletal muscle fibrosis in mice using nuclear magnetic resonance imaging and ultrasound shear wave elastography AB Martins-Bach, D Bachasson, ECA Araujo, L Soustelle, ... Scientific Reports 11 (1), 284, 2021 | 14 | 2021 |
| Dmdmdx/Largemyd: a new mouse model of neuromuscular diseases useful for studying physiopathological mechanisms and testing therapies PCM Martins, D Ayub-Guerrieri, AB Martins-Bach, P Onofre-Oliveira, ... Disease Models & Mechanisms 6 (5), 1167-1174, 2013 | 10 | 2013 |
| 265th ENMC International Workshop: Muscle imaging in Facioscapulohumeral Muscular Dystrophy (FSHD): relevance for clinical trials. 22–24 April 2022, Hoofddorp, The Netherlands M Monforte, S Attarian, J Vissing, J Diaz-Manera, G Tasca, R Badiani, ... Neuromuscular Disorders 33 (1), 65-75, 2023 | 4 | 2023 |
| Mutation in the FUS nuclear localisation signal domain causes neurodevelopmental and systemic metabolic alterations Z Ali, JM Godoy-Corchuelo, AB Martins-Bach, I Garcia-Toledo, ... Disease Models & Mechanisms 16 (10), 2023 | 1 | 2023 |
| 7, 8-dihydroxyflavone enhances long-term spatial memory and alters brain volume in wildtype mice F Rawlings-Mortimer, A Lazari, C Tisca, M Tachrount, AB Martins-Bach, ... Frontiers in Systems Neuroscience 17, 1134594, 2023 | 1 | 2023 |
| Vcan mutation leads to sex-specific changes in white matter microstructure in mice C Tisca, M Tachrount, F Lange, C Wang, L Qiu, J Barallobre-Barreiro, ... ISMRM & SMRT Virtual Conference, 2021 | 1 | 2021 |
| Anatomical and microstructural brain alterations in the TDP-M323K mouse model of amyotrophic lateral sclerosis AB Martins-Bach, M Tachrount, C Tisca, L Qiu, S Spring, J Ellegood, ... International Society of Magnetic Resonance in Medicine 1208, 2021 | 1 | 2021 |
| DP 16 Metabolic and hemodynamic alterations in the mdx skeletal muscle revisited using multi-parametric functional NMR B Matot, G Jouvion, AB Martins-Bach, C Wary, PG Carlier Neuromuscular Disorders 22 (9), 822-823, 2012 | 1 | 2012 |
| P1. 45 Application of NMR spectroscopy in the study of mdx mouse AB Martins-Bach, AC Bloise, SR Rabbani, M Vainzof Neuromuscular Disorders 21 (9), 655, 2011 | 1 | 2011 |
| TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43 JM Godoy-Corchuelo, Z Ali, JMB Armas, AB Martins-Bach, ... Neurobiology of Disease, 106437, 2024 | | 2024 |
| Lasting dynamic effects of the psychedelic 2, 5-dimethoxy-4-iodoamphetamine ((±)-DOI) on cognitive flexibility M Šabanović, A Lazari, M Blanco-Pozo, C Tisca, M Tachrount, ... Molecular Psychiatry, 1-14, 2024 | | 2024 |
| Protocol for tissue processing and paraffin embedding of mouse brains following ex vivo MRI A Smart, C Tisca, IN Huszar, D Kor, O Ansorge, M Tachrount, S Smart, ... STAR protocols 4 (4), 102681, 2023 | | 2023 |
| FUSDELTA14 MUTATION IMPAIRS NORMAL BRAIN DEVELOPMENT AND CAUSES SYSTEMIC METABOLIC ALTERATIONS. JMG Corchuelo, Z Ali, I Garcia-Toledo, L Fernandez-Beltran, ... IBRO Neuroscience Reports 15, S94-S95, 2023 | | 2023 |
| FUSDelta14 mutation impairs normal brain development and causes systemic metabolic alterations JM Godoy-Corchuelo, Z Ali, AB Martins-Bach, I Garcia-Toledo, ... bioRxiv, 2023.02. 24.529858, 2023 | | 2023 |
